Ownership history in MACQUARIE GROUP LTD · 14 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 833,437 | -115,413 | -12.2% | 0.06% | $49.5M | $59.43 |
| 2025 Q2 | ADDED | 948,850 | +56,069 | +6.3% | 0.05% | $38.4M | $40.51 |
| 2025 Q1 | ADDED | 892,781 | +76,869 | +9.4% | 0.06% | $45.9M | $51.37 |
| 2024 Q4 | ADDED | 815,912 | +221,034 | +37.2% | 0.05% | $45.2M | $55.37 |
| 2024 Q3 | ADDED | 594,878 | +139,887 | +30.7% | 0.02% | $19.6M | $32.89 |
| 2024 Q2 | ADDED | 454,991 | +304,991 | +203.3% | 0.01% | $12.4M | $27.18 |
| 2024 Q1 | UNCHANGED | 150,000 | — | 0% | 0.01% | $5.5M | $36.35 |
| 2023 Q4 | UNCHANGED | 150,000 | — | 0% | 0.00% | $3.0M | $20.25 |
| 2023 Q3 | UNCHANGED | 150,000 | — | 0% | 0.00% | $2.7M | $17.77 |
| 2023 Q2 | UNCHANGED | 150,000 | — | 0% | 0.00% | $2.7M | $18.07 |
As of 2025 Q4 — sorted by position size